BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,842,878 | -13.8% | 393,293 | +4.1% | 0.51% | -11.2% |
| Q2 2023 | $17,211,429 | +8.2% | 377,775 | -3.7% | 0.57% | +0.7% |
| Q1 2023 | $15,912,702 | -24.9% | 392,325 | -5.6% | 0.57% | -25.4% |
| Q4 2022 | $21,183,693 | -10.6% | 415,611 | -5.5% | 0.76% | -16.3% |
| Q3 2022 | $23,700,000 | +0.3% | 440,028 | +19.6% | 0.91% | +6.9% |
| Q2 2022 | $23,640,000 | -14.5% | 368,053 | +3.3% | 0.85% | +2.5% |
| Q1 2022 | $27,638,000 | -47.0% | 356,433 | -41.3% | 0.83% | -43.9% |
| Q4 2021 | $52,144,000 | +76.7% | 607,454 | +65.5% | 1.48% | +63.9% |
| Q3 2021 | $29,518,000 | +116.6% | 367,002 | +116.8% | 0.90% | +121.6% |
| Q2 2021 | $13,629,000 | +1.2% | 169,307 | +6.1% | 0.41% | -3.6% |
| Q1 2021 | $13,463,000 | +16.0% | 159,631 | +10.4% | 0.42% | +9.6% |
| Q4 2020 | $11,607,000 | +12.9% | 144,657 | +13.2% | 0.38% | +2.1% |
| Q3 2020 | $10,278,000 | -7.2% | 127,810 | -0.6% | 0.38% | -13.3% |
| Q2 2020 | $11,070,000 | +4.3% | 128,576 | -1.6% | 0.44% | -14.7% |
| Q1 2020 | $10,614,000 | -3.1% | 130,726 | -0.2% | 0.51% | +31.1% |
| Q4 2019 | $10,948,000 | +5.3% | 130,928 | +10.2% | 0.39% | -1.3% |
| Q3 2019 | $10,394,000 | +6.6% | 118,833 | -0.2% | 0.39% | +6.8% |
| Q2 2019 | $9,749,000 | +0.6% | 119,033 | -0.2% | 0.37% | -1.6% |
| Q1 2019 | $9,694,000 | +117.9% | 119,228 | +76.4% | 0.38% | +92.3% |
| Q4 2018 | $4,449,000 | -17.6% | 67,586 | -3.5% | 0.20% | +2.1% |
| Q3 2018 | $5,399,000 | +3.5% | 70,030 | -0.9% | 0.19% | -2.1% |
| Q2 2018 | $5,217,000 | +13.4% | 70,655 | -0.1% | 0.20% | +12.7% |
| Q1 2018 | $4,602,000 | -2.9% | 70,755 | -3.5% | 0.17% | +6.1% |
| Q4 2017 | $4,739,000 | +1.2% | 73,310 | -1.8% | 0.16% | 0.0% |
| Q3 2017 | $4,685,000 | +3.7% | 74,660 | 0.0% | 0.16% | +4.5% |
| Q2 2017 | $4,520,000 | +17.4% | 74,660 | +0.6% | 0.16% | +14.7% |
| Q1 2017 | $3,849,000 | +31.8% | 74,210 | +12.7% | 0.14% | +28.3% |
| Q4 2016 | $2,920,000 | -5.4% | 65,865 | +1.5% | 0.11% | -5.4% |
| Q3 2016 | $3,088,000 | +17.0% | 64,865 | +11.1% | 0.11% | +16.7% |
| Q2 2016 | $2,639,000 | +94.9% | 58,365 | +77.1% | 0.10% | +95.9% |
| Q1 2016 | $1,354,000 | +43.3% | 32,965 | +33.1% | 0.05% | +58.1% |
| Q4 2015 | $945,000 | +4.9% | 24,765 | -9.7% | 0.03% | +6.9% |
| Q3 2015 | $901,000 | -57.6% | 27,440 | -9.6% | 0.03% | -51.7% |
| Q2 2015 | $2,123,000 | -1.3% | 30,355 | -3.3% | 0.06% | -3.2% |
| Q1 2015 | $2,150,000 | -4.5% | 31,385 | +2.1% | 0.06% | -7.5% |
| Q4 2014 | $2,252,000 | +6.0% | 30,725 | +3.8% | 0.07% | +1.5% |
| Q3 2014 | $2,125,000 | +8.4% | 29,610 | +9.2% | 0.07% | +10.0% |
| Q2 2014 | $1,961,000 | +2.2% | 27,125 | +4.1% | 0.06% | -4.8% |
| Q1 2014 | $1,918,000 | -27.4% | 26,065 | -35.2% | 0.06% | -55.9% |
| Q3 2013 | $2,643,000 | -17.7% | 40,235 | -13.2% | 0.14% | -23.5% |
| Q2 2013 | $3,210,000 | – | 46,335 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |